Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.
D000077443:Acamprosate; D000427:Alcohol Deterrents / Q000008:administration & dosage / Q000627:therapeutic use*; D000437:Alcoholism / Q000188:drug therapy*; D005060:Europe; D006801:Humans; D015201:Meta-Analysis as Topic; D009271:Naltrexone / Q000008:administration & dosage / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects; D013654:Taurine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016896:Treatment Outcome
D000427:Alcohol Deterrents; D009292:Narcotic Antagonists; D010919:Placebos; D016194:Receptors, N-Methyl-D-Aspartate; D013654:Taurine; D009271:Naltrexone; D000077443:Acamprosate